GLI1 and acute promyelocytic leukemia: Arsenic Trioxide (ATO) is an organic compound approved for the therapy of adult patients with acute promyelocytic leukemia [25] and was shown to successfully inhibit both HH-GLI and NOTCH pathways [26].